Three Presentations of Phase 1 Clinical Data for TRX-248 Transdermal System at the 2026 Pulmonary Hypertension Association ...
Corsair Pharma Announces Positive Phase 1 Results for the TRX-248 Transdermal System in Pulmonary Arterial Hypertension ...
Corsair Pharma's skin-worn patch designed to deliver the PAH treatment treprostinil appears to be working as intended, early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results